Search
Home
Latest News
Features
Profiles
Videos
Events
Supplements
Past Issues
Subscriptions
Cardiac Rhythm News
Cardiac Rhythm News is a one-stop source of news and opinion in the Cardiac Rhythm management world.
Home
Latest News
Features
Profiles
Videos
Events
Supplements
Past Issues
Subscriptions
Home
Search
direct oral anticoagulants
-
search results
If you're not happy with the results, please do another search
Latest News
Alternative timing method for direct oral anticoagulants following ischaemic stroke with atrial fibrillation deemed feasible
Sarah Croft
-
16th February 2022
0
Latest News
Boston Scientific initiates trial comparing left atrial appendage closure to direct oral anticoagulants for stroke risk reduction post-AFib ablation
Jocelyn Hudson
-
23rd May 2019
0
Latest News
Apixaban associated with lower risk of gastrointestinal bleeding in AF patients compared to other oral anticoagulants
willdate
-
1st November 2022
0
Latest News
Anticoagulants fail to improve survival from COVID-19, Swedish study finds
willdate
-
2nd December 2020
0
Latest News
ACC publishes pathway on the management of bleeding in patients on oral anticoagulants
willdate
-
15th July 2020
0
Features
Risk of dementia higher without oral anticoagulants for AF
zohman
-
15th December 2017
0
Latest News
AF patients with intermediate-to-high-risk of stroke often prescribed aspirin instead of anticoagulants
BIBA Publishing
-
21st June 2016
0
Latest News
Verseon presents data on new class of anticoagulants at the 8th Biotech Showcase conference
BIBA Publishing
-
15th January 2016
0
Latest News
Insertable cardiac monitors may help decide safe discontinuation of oral anticoagulation in AF patients at high risk of bleeding
BIBA Publishing
-
4th December 2015
0
Features
ENSURE-AF: Largest trial ever to explore novel oral anticoagulation in AF patients undergoing cardioversion
BIBA Publishing
-
10th February 2015
0
Latest News
Novel oral anticoagulants an option for patients with atrial fibrillation
BIBA Publishing
-
26th June 2014
0
Features
Clinical strategies for selecting oral anticoagulants in atrial fibrillation patients
BIBA Publishing
-
17th October 2013
0
Latest News
Indirect comparison of new anticoagulants provides insight into how the drugs compare
BIBA Publishing
-
14th August 2012
0
Latest News
Watchman device shows 75% reduction in stroke risk in patients with atrial fibrillation not eligible for oral anticoagulation therapy
BIBA Publishing
-
14th May 2012
0
Latest News
Edoxaban: Next generation oral anticoagulant under investigation
BIBA Publishing
-
7th September 2009
0
Latest News
LAAC-related ischaemic stroke “less severe and less fatal” than with DOACs in AF patients
willdate
-
27th November 2023
0
Latest News
Early anticoagulation after ischaemic stroke “reasonable” and “unlikely to cause harm”
jamiebell
-
30th May 2023
0
Latest News
Experts update consensus on left atrial appendage closure
willdate
-
31st March 2023
0
Latest News
HRS 2021: DOACs reduce risk of stroke in patients undergoing left ventricular RFA
willdate
-
30th July 2021
0
Latest News
DOACs show better safety and effectiveness versus warfarin in patients with valvular AF
willdate
-
1st April 2021
0
Latest News
AHA 2020: Rivaroxaban may be comparable to warfarin for bioprosthetic mitral valves, AF
willdate
-
16th November 2020
0
Videos
President of Venice Arrhythmias discusses current challenges in atrial fibrillation management
Jocelyn Hudson
-
9th October 2019
0
Latest News
Analysis of the BRUISE CONTROL 1 and 2 trials shows no difference in clinically significant haematoma between DOACs and warfarin
hannahwoolley
-
27th June 2018
0
Latest News
New guidelines promote safety for patients on antithrombotic drugs undergoing anaesthesia or pain intervention
hannahwoolley
-
10th April 2018
0
Latest News
Less bleeding in ablation with interrupted dabigatran compared to uninterrupted warfarin
hannahwoolley
-
24th January 2018
0
Features
Antithrombotic therapy after left atrial appendage closure
BIBA Publishing
-
10th September 2014
0
Latest News
AZALEA-TIMI 71 Phase 2 study ends early after “overwhelming” endpoint reduction
willdate
-
19th September 2023
0
Latest News
Early rhythm control aids recurrent stroke prevention in patients with AF
Éva Malpass
-
2nd March 2023
0
Latest News
ESC 2021: Edoxaban shown to be noninferior to warfarin for adverse events after TAVI
Anthony Strzalek
-
6th September 2021
0
Latest News
ACC.21: Registry data show low rate of stroke at one year following LAAO with Watchman
willdate
-
16th May 2021
0
Latest News
Boston Scientific initiates CHAMPION-AF trial of Watchman FLX
willdate
-
29th October 2020
0
Latest News
ESC Congress 2020: Guidelines push individualised approach to AF
willdate
-
29th August 2020
0
Latest News
First procedures performed in the USA using Watchman FLX LAAC device
willdate
-
10th August 2020
0
Features
Prompt diagnosis “vital” in effective AF management
willdate
-
30th July 2020
1
Latest News
AF Symposium 2020: Use-as-needed NOAC strategy is safe and effective for selected AF patients
dawnpowell
-
24th January 2020
0
Latest News
Pooled analysis shows LAAC is cheaper than drug therapy for AF
Angela O'Neill
-
5th July 2019
0
Latest News
White paper from Heart Rhythm Society suggests Afib treatment has reached a “turning point”
Angela O'Neill
-
6th June 2019
0
Latest News
CE mark for Watchman FLX left atrial appendage closure device
Jocelyn Hudson
-
13th March 2019
0
Latest News
Apixaban is a safe alternative to warfarin during catheter ablation of atrial fibrillation and may have a positive effect on cognitive function
hannahwoolley
-
1st June 2018
0
Latest News
Point-of-care testing of coagulation in patients treated with edoxaban
hannahwoolley
-
31st May 2018
0
Latest News
Octreotide enables left atrial appendage closure in AF patients with GI bleeding
hannahwoolley
-
31st May 2018
0
Profiles
Nassir Marrouche
hannahwoolley
-
4th May 2018
0
Latest News
Dabigatran consistently shown to decrease risk of brain bleeds compared to warfarin
zohman
-
15th November 2017
0
Latest News
Vivek Reddy on the final outcomes of PREVAIL and PROTECT-AF
zohman
-
3rd November 2017
0
Latest News
Significant differences among atrial fibrillation patients across Asia
dawnpowell
-
18th September 2017
0
Profiles
Carlos Morillo
Angela O'Neill
-
15th June 2017
0
Latest News
Four out of 10 AF patients may not receive necessary stroke-prevention medication
amanda
-
15th May 2017
0
Latest News
Surgical left atrial appendage occlusion reduces thromboembolic stroke and mortality in older AF patients
Angela O'Neill
-
4th May 2017
0
Latest News
ACC 2017: Uninterrupted dabigatran performs better than warfarin in atrial fibrillation ablation
Angela O'Neill
-
21st March 2017
0
Latest News
Case strengthens for opportunistic atrial fibrillation screening
Angela O'Neill
-
5th January 2017
0
Latest News
Health Canada approves edoxaban for two indications
amanda
-
10th November 2016
0
Latest News
Portola license Japanese commercial rights for andexanet alfa to Bristol-Myers Squibb and Pfizer
BIBA Publishing
-
2nd February 2016
0
Latest News
NICE recommends once-daily Lixiana (edoxaban) for preventing stroke and systemic embolism in non-valvular atrial fibrillation patients
BIBA Publishing
-
23rd September 2015
0
Latest News
First patient enrolled in study of Eliquis (apixaban) in NVAF patients with recent acute coronary syndrome or undergoing PCI
BIBA Publishing
-
10th September 2015
0
Latest News
Global registry presents two-year outcomes data in more than 17,000 newly-diagnosed AF patients
BIBA Publishing
-
2nd September 2015
0
Features
Highlights EHRA EUROPACE-CARDIOSTIM 2015: Interview with Michael Glikson
BIBA Publishing
-
16th July 2015
0
Latest News
Benefit of anticoagulation in AF patients with a low risk of stroke questioned
BIBA Publishing
-
18th June 2015
0
Latest News
First patient enrolled in dabigatran study comparing anticoagulation strategies during atrial fibrillation ablation
BIBA Publishing
-
26th May 2015
0
Latest News
Phase 3 ANNEXA-R study of andexanet alfa and factor Xa inhibitor Xarelto meets primary endpoint
BIBA Publishing
-
5th February 2015
0
Features
Get With The Guidelines-AFIB: A US quality improvement programme for atrial fibrillation patients
BIBA Publishing
-
27th January 2015
0
Profiles
Massimo Santini
BIBA Publishing
-
10th October 2014
0
Latest News
Joint consensus on antithrombotic use in AF patients with acute coronary syndrome published
BIBA Publishing
-
27th August 2014
0
Latest News
Bristol-Myers Squibb and Pfizer to present new Eliquis (apixaban) data at ESC
BIBA Publishing
-
22nd August 2014
0
Latest News
New study of Pradaxa to explore anticoagulation in ablation of AF patients
BIBA Publishing
-
20th June 2014
0
Latest News
Daiichi Sankyo initiates phase 3 ENSURE-AF study
BIBA Publishing
-
1st April 2014
0
Latest News
Detection of atrial fibrillation with insertable cardiac monitors is superior to standard monitoring in cryptogenic stroke patients
BIBA Publishing
-
20th February 2014
0
Features
Rivaroxaban prevents prothrombogenic remodelling of human atrial myocardium
BIBA Publishing
-
18th December 2013
0
Latest News
UK’s NICE supports improved commissioning for anticoagulation therapy for adults
BIBA Publishing
-
15th May 2013
0
Latest News
Rivaroxaban to be studied with Factor Xa inhibitor antidote
BIBA Publishing
-
6th February 2013
0
Features
The use of dabigatran in clinical practice
BIBA Publishing
-
28th January 2013
0
Profiles
Gregory YH Lip
BIBA Publishing
-
23rd January 2013
0
Latest News
European Commission approves apixaban for prevention of stroke and systemic embolism in non-valvular atrial fibrillation patients
BIBA Publishing
-
21st November 2012
0
Latest News
Dabigatran etexilate recommended for approval for stroke prevention in AF patients in Europe
BIBA Publishing
-
27th April 2011
0
Features
Worldwide survey shows ablation works without drugs in most cases
BIBA Publishing
-
7th July 2010
0
Profiles
Riccardo Cappato
BIBA Publishing
-
16th July 2009
0
Latest News
Voice response system useful for monitoring anticoagulant patients
BIBA Publishing
-
28th April 2009
0
Latest News
Final patient completes treatment in the RE-LY study
BIBA Publishing
-
23rd March 2009
0